Business / Finance

RSS

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.

24 Jan 2014

Covidien announces financial results for first quarter of fiscal 2014

Covidien plc today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of $2.64 billion increased 3% from the $2.57 billion in the first quarter a year ago. Operational sales growth in the quarter was 5%, as foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.

24 Jan 2014

SCL Health System and Univita Health jointly acquire All Care Home Health

SCL Health System, along with its joint venture partner, Univita Health, announced today the acquisition of Denver-based All Care Home Health LLC. Terms were not disclosed.

23 Jan 2014

Quality Systems third quarter revenues decrease 5% to $108.9 million

Quality Systems, Inc. announced today results for its fiscal 2014 third quarter ended December 31, 2013.

23 Jan 2014

ACM Global acquires Phoenix PCS to expand operation in the Asia Pacific region

ACM Global Central Laboratory, a diagnostic central laboratory specializing in delivering high quality testing services which optimize clinical trial outcomes, today announced it has acquired Phoenix Pharma Central Services Pte. Ltd, a premier central laboratory services provider for Asia Pacific clinical trials, with laboratory facilities in Singapore and Shanghai, China. The acquisition enables ACM Global to deliver increased operational and financial efficiencies to clients conducting clinical studies in the Asia Pacific region. Terms of the transaction were not disclosed.

23 Jan 2014

A*STAR and Nestle sign agreement to advance research on nutrition in Singapore

Singapore's Agency for Science, Technology and Research has entered into a research agreement with Nestl- today to help boost the company's expansion in R&D in the country.

23 Jan 2014

St. Jude Medical reports net sales of $1.422 billion in fourth quarter 2013

St. Jude Medical, Inc. today reported sales and net earnings for the fourth quarter and full year ended Dec. 28, 2013.

22 Jan 2014

FSMB joins with partners to educate health care professionals on safe prescribing of opioid analgesics

The Federation of State Medical Boards (FSMB) and FSMB Foundation are collaborating with several partners to provide state medical boards with resources to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.

22 Jan 2014

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.

21 Jan 2014

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $31.6 million debt financing expansion with Proteus Digital Health. The financing package, which was provided to Proteus Digital Health from both Oxford and Silicon Valley Bank, included a senior secured term loan and a revolving line of credit. Proceeds of the loan will be used for working capital growth.

21 Jan 2014

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

Trendlines Labs (a unit of the Trendlines Group) recently signed an agreement for collaboration with Roper St. Francis Healthcare.

21 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

DATATRAK partners with Clinverse to reduce complexity and costs linked with clinical trials

DATATRAK International, Inc., a leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its newest DATATRAK Connect Technology Partner, Clinverse, Inc. Clinverse architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials.

21 Jan 2014

Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

Sigma-Aldrich Corporation, a leading Life Science and High Technology Company, today announced the signing of an agreement with Goodfellow Cambridge, Ltd., a leading international supplier of metals and materials for research and industry, to market and distribute Goodfellow's portfolio of materials which includes metals, alloys and ceramics.

21 Jan 2014

NuPathe terminates merger agreement with Endo Health Solutions

Endo Health Solutions today announced that NuPathe Inc. has terminated its merger agreement with Endo. Endo has received a $5 million termination fee from NuPathe.

21 Jan 2014

PLSG reaches significant landmark in direct investments into life sciences companies

Pittsburgh Life Sciences Greenhouse, the region's only pure life sciences investment firm, and managing member of the PLSG Accelerator Fund, announced today it has made a $65,000 investment into Cohera Medical, Inc. which launches the organization into a $20 million milestone in total investments since the company's inception in 2001.

21 Jan 2014

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

Par Pharmaceutical Companies, Inc. today announced that it has entered into a definitive agreement to acquire JHP Group Holdings, the parent company of JHP Pharmaceuticals, a leading specialty pharmaceutical company that develops, manufactures and markets branded and generic sterile injectable products.

21 Jan 2014

Watercrest Senior Living Group finalizes $500M co-development partnership

Watercrest Senior Living Group of Vero Beach, FL, and Index International AB, headquartered in Stockholm, Sweden, announce the finalization of their $500 million partnership in the co-development of senior living communities in the United States.

21 Jan 2014

Illumina inks multi-year supply agreement with LabCorp

Illumina, Inc. today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America Holdings. The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing and microarray equipment and supplies to develop, validate and introduce laboratory-developed tests to clinicians in the United States and Canada.

From Illumina, Inc. 21 Jan 2014

Synthelis secures initial funding to accelerate commercial development of membrane proteins

Synthelis, a company specializing in the production and characterization of therapeutic targets and antigens, announces today that it has secured initial backing of EUR 610,000 from a group of French investors comprising Rhone-Alpes Creation, Alpes Developpement Durable Investissement (A2D-Invest), Sud Rhone-Alpes Capital, Viaduc and the Savoy and Grenoble Business Angels networks.

21 Jan 2014

Business / Finance

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Covidien announces financial results for first quarter of fiscal 2014

SCL Health System and Univita Health jointly acquire All Care Home Health

Quality Systems third quarter revenues decrease 5% to $108.9 million

ACM Global acquires Phoenix PCS to expand operation in the Asia Pacific region

A*STAR and Nestle sign agreement to advance research on nutrition in Singapore

St. Jude Medical reports net sales of $1.422 billion in fourth quarter 2013

FSMB joins with partners to educate health care professionals on safe prescribing of opioid analgesics

HUB Foundation for Organoid Technology signs licensing agreement with STEMCELL Technologies

Oxford Finance closes $31.6M debt financing expansion with Proteus Digital Health

Trendlines Labs signs deal for collaboration with Roper St. Francis Healthcare

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

DATATRAK partners with Clinverse to reduce complexity and costs linked with clinical trials

Sigma-Aldrich and Goodfellow Cambridge join forces to distribute ceramics, metals and alloys

NuPathe terminates merger agreement with Endo Health Solutions

PLSG reaches significant landmark in direct investments into life sciences companies

Par Pharmaceutical enters into definitive agreement to purchase JHP Group Holdings

Watercrest Senior Living Group finalizes $500M co-development partnership

Illumina inks multi-year supply agreement with LabCorp

Synthelis secures initial funding to accelerate commercial development of membrane proteins

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News